final dosage form
(10) The term “final dosage form” means, with respect to a biosimilar biological product, a finished dosage form which is approved for administration to a patient without substantial further manufacturing (such as lyophilized products before reconstitution).
21 USC § 379j-51(10)
None identified. Default scope is assumed to be the entire title.